LGVN News and Press, Longeveron Inc. From 11/25/21

Are These The Best Health Care Stocks To Buy Right Now? Whether it is health care stocks , vaccine stocks, or telehealth stocks, investors appear to be eyeing the health care world. For the most part, this would be the case in the stock market today as Covid-19 appears to be ret...

The apparent short squeeze that began last week in Longeveron (LGVN +122.3%) is continuing today as the share price has more than doubled. The stock took a breather yesterday, closing down 29%. Longeveron was initially boosted on Nov. 18 after the FDA granted Rare Pediatric Disease desig...

Gainers: Biofrontera (NASDAQ:BFRI) +154%. Longeveron (NASDAQ:LGVN) +79%. Ocuphire Pharma (NASDAQ:OCUP) +36%. Society Pass (NASDAQ:SOPA) +24%. Biofrontera (NASDAQ:BFRA) +23%. Better Therapeutics (NASDAQ:BTTX) +20%. Applied UV (NASDAQ:AUVI) +19%. Standard Lithium (NYSE:SLI) +19%. Blue Star Food...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Autodesk (NASDAQ: ADSK ) stock is taking a beating on Wednesday after the software company reported mixed earnings for its fiscal third quarter of 2022. Source: JHVEPhoto / Shutterstock.com Let’s get th...

Shares of Longeveron (NASDAQ: LGVN) were skyrocketing 72.9% as of 11:51 a.m. ET on Wednesday after more than doubling earlier in the day. The company didn't report any new developments. So what's behind the huge gain? An epic short squeeze appears to be underway. Longeveron ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the best-performing stocks in the market in recent weeks has been Longeveron (NASDAQ: LGVN ). Today, LGVN stock is soaring once again, up nearly 80% at the time of writing, on five times the average daily vol...

Longeveron Inc. (NASDAQ:LGVN) traded today at a new 52-week high of $35.00. Approximately 28.5 million shares have changed hands today, as compared to an average 30-day volume of 17.8 million shares. Longeveron Inc is a biotechnology company developing cellular therapies for specific age...

Gainers: Biofrontera (NASDAQ:BFRI) +109%, Longeveron (NASDAQ:LGVN) +87%, Ocuphire Pharma (NASDAQ:OCUP) +41%, Better Therapeutics (NASDAQ:BTTX) +24%, Reviva Pharmaceuticals (NASDAQ:RVPH) +12%. Losers: Vallon Pharmaceuticals (NASDAQ:VLON) -34%, Pasithea Therap...

Ocuphire Pharma (NASDAQ:OCUP) +74%. Biofrontera (NASDAQ:BFRI) +53%. Engine Gaming and Media (NASDAQ:GAME) +30% on FY results Longeveron (NASDAQ:LGVN) +16%. Inspira Technologies Oxy (NASDAQ:IINN) +15%. Society Pass Incorporated  (NASDAQ:SOPA) +15% on no apparent news Spark Netwo...

Gainers: Pasithea Therapeutics (NASDAQ:KTTA) +257%, Petros Pharmaceuticals (NASDAQ:PTPI) +73%, Gracell Biotechnologies (NASDAQ:GRCL) +64%, iSpecimen (NASDAQ:ISPC) +43%, Qualigen Therapeutics (NASDAQ:QLGN) +33%. Losers: Longeveron (NASDAQ:LGVN) -36%...